Applications open

Regulatory Strategy Sprint

Confirm your medical device classification and global market entry pathway. Leave with a documented regulatory strategy and intended use statements to support your investor due diligence.

DEADLINE: November 30
Regulatory Strategy Sprint

Program Outcomes

By the end of this program, you will have a clear regulatory strategy and timeline you can execute against and share with stakeholders.

  1. Product classification across FDA, Health Canada, and EU MDR

  2. A documented regulatory pathway with submission requirements

  3. Precise intended use and indications for use statements

  4. A phased global commercialization timeline with regulatory dependencies

  5. An investor-ready regulatory milestone document

Already trusted by Rellia members

“As an early-stage medtech company navigating regulatory readiness, having a structured system with clear guidance made a huge difference. The templates were practical and startup-friendly, the process was easy to follow, and the support helped us understand not just what needed to be done, but how to do it properly.”

Ibukun Elebute

Ibukun Elebute

Founder & COO • Cellect

“Rellia has been excellent to work with and has played an integral role in building our regulatory plans. I would highly recommend them to anyone looking to navigate regulatory submissions for a medical-related product. They are true experts in their field.”

Dr Stevie Foglia

Dr Stevie Foglia

Founder & CEO • Neuro-Mod

0 / 0

How It Works

Work with regulatory experts to classify your device, choose the right pathway, and build a timeline investors trust.

Classification & Pathway

Determine your product's device classification across FDA, Health Canada, and EU MDR — and map the fastest viable regulatory pathway for each market.

Intended Use Documentation

Draft precise intended use and indications for use statements that align your regulatory, clinical, and commercial strategy from the start.

Global Market Strategy

Build a phased commercialization timeline across key markets, understanding the regulatory dependencies and milestones investors expect to see.

Program Pillars

Pathway Clarity

Understand exactly which regulatory submissions you need, in what order, and what evidence each requires.

Risk-Based Approach

Use ISO 14971 risk management principles to inform your classification and submission strategy from day one.

Investor Alignment

Frame your regulatory strategy as a de-risking milestone that builds investor confidence in your timeline.

Actionable Roadmap

Leave with a documented regulatory strategy and timeline you can execute against and share with stakeholders.

Program Timeline & Details

4 weeks to build your regulatory roadmap from classification to market

Step 1

Step 2

Step 3

Step 4

Applications open

$2,000

Leave with a documented regulatory strategy and milestone timeline you can execute against and share with investors.

What's included

  • Multi-jurisdiction classification
  • Pathway selection guidance
  • Intended use statement drafting
  • Regulatory milestone timeline

Not sure if your product needs a regulatory pathway?

Many health tech products require regulatory clearance — but not all do. Reach out and we'll help you figure out where you stand.